NEOGEN CHEMICALS
Market cap ₹8,352 Cr
- P/E
- 193.61
- Day range
- ₹2,686.00 – ₹2,832.00
- 52-week range
- ₹966.70 – ₹2,875.00
- Volume
- 7.45 L
- Open
- ₹2,764.80
- Prev close
- ₹2,778.60
Latest results · Q2 FY27(consolidated)Revenue ₹296 Cr+41.8%Profit ₹8 Cr+144.2%Margin 2.8%YoY vs the same quarter last year
1 red flag to read up on
- medium
Promoter holding falling
48.31%, down 2.92 pts since 2026-03-31 · 30 Sept 2026
From NSE and BSE filings. A flag is a reason to read the filing, not a rating.
NEOGEN in NSE indices and F&O
Research profile
Composite 45 / 100Factor percentiles
Derived metrics
- Earn. yield
- 0.5%
- Graham no.
- ₹406.24
- vs Graham
- -85.4%
- ROE ÷ P/B
- 0.7%
- 12-1 mom.
- +89.9%
- Return / vol
- 2.24
- Magic Formula
- #610
- Piotroski
- 4/6
- FCF yield
- -9.4%
- PEG
- 1.34
Appears in 17 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Chemicals| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Solar IndustriesSOLARINDS | ₹1.68 L Cr | 74.04 | 22.19 | 32.5% | 38.0% | 29.0% | 0.23 | +69.0% |
| Pidilite IndustriesPIDILITIND | ₹1.56 L Cr | 58.12 | 14.05 | 24.0% | 31.0% | 20.0% | 0.03 | +20.9% |
| SRF LtdSRF | ₹72,471 Cr | 31.75 | 4.80 | 13.8% | 15.0% | 19.0% | 0.35 | +34.7% |
| Linde IndiaLINDEINDIA | ₹58,548 Cr | 118.46 | 13.42 | 13.6% | 18.0% | 32.0% | 0.23 | +12.3% |
| Coromandel InternationalCOROMANDEL | ₹57,701 Cr | 37.01 | 4.30 | 16.1% | 22.0% | 9.0% | 0.12 | +6.6% |
| Gujarat FluorochemicalsFLUOROCHEM | ₹52,952 Cr | 78.39 | 6.17 | 7.6% | 10.0% | 27.0% | 0.28 | +45.5% |
| Navin Fluorine InternationalNAVINFLUOR | ₹52,759 Cr | 57.95 | 11.37 | 20.1% | 21.0% | 34.0% | 0.28 | +57.1% |
| NEOGEN CHEMICALSNEOGEN | ₹8,352 Cr | 193.61 | 5.09 | 3.6% | 6.0% | 15.3% | 1.04 | +41.8% |
| Sector median | ₹13,505 Cr | 31.75 | 2.86 | 9.9% | 12.0% | 15.7% | 0.27 | +21.5% |
Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 9h agoHeadlines about NEOGEN CHEMICALS from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 199.0
- Price / Book
- 5.30
- ROE (FY26)
- 3.6%
- ROCE (latest year)
- 6%
- Dividend yield
- 0.04%
Moving averages (NSE)
- 20-day
- ₹2,433.57
- Price above
- 50-day
- ₹2,409.43
- Price above
- 200-day
- ₹1,896.99
- Price above
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- DII
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 164.44 | 199.65 | 179.95 | 193.36 | 201.43 | 202.82 | 186.73 | 208.66 | 220.02 | 246.56 | 250.29 | 295.96 |
| YoY Sales growth | -11.71 | -2.09 | — | — | — | — | — | — | — | — | — | — |
| Expenses | 144.15 | 163.86 | 149.15 | 158.85 | 166.79 | 166.44 | 155.22 | 178.70 | 188.12 | 202.65 | 202.06 | 250.64 |
| Operating Profit | 20.29 | 35.79 | 30.80 | 34.51 | 34.64 | 36.38 | 31.51 | 29.96 | 31.90 | 43.91 | 48.23 | 45.32 |
| OPM % | 12.3% | 17.9% | 17.1% | 17.9% | 17.2% | 17.9% | 16.9% | 14.4% | 14.5% | 17.8% | 19.3% | 15.3% |
| Other Income | 1.67 | 2.23 | 1.59 | 0.84 | 1.14 | -13.44 | 1.23 | 1.98 | 2.20 | 1.01 | 4.06 | 3.97 |
| Interest | 10.52 | 9.69 | 9.82 | 12.75 | 13.43 | 12.50 | 12.67 | 19.48 | 21.51 | 21.47 | 20.81 | 27.78 |
| Depreciation | 5.74 | 5.86 | 6.81 | 7.12 | 7.10 | 6.76 | 5.78 | 7.31 | 6.83 | 7.60 | 8.20 | 8.79 |
| Profit before tax | 5.70 | 22.47 | 15.76 | 15.48 | 15.25 | 3.68 | 14.29 | 5.15 | 5.76 | 15.85 | 23.28 | 12.72 |
| Tax % | 81.4% | 24.7% | 27.2% | 29.2% | 34.4% | 34.5% | 28.2% | 34.6% | 35.9% | 28.1% | 26.5% | 35.3% |
| Net Profit | 1.06 | 16.93 | 11.47 | 10.96 | 10.01 | 2.41 | 10.26 | 3.37 | 3.69 | 11.39 | 17.11 | 8.23 |
| EPS in Rs | ₹0.40 | ₹6.42 | ₹4.35 | ₹4.15 | ₹3.79 | ₹0.91 | ₹3.89 | ₹1.28 | ₹1.40 | ₹4.32 | ₹6.25 | ₹2.74 |
From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
+76 days since Mar 2021
+234 days since Mar 2021
+224 days since Mar 2021
+86 days since Mar 2021
+19 days since Mar 2021
Strengths, risks & growth
Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]
Strengths
- Company is expected to give good quarter
- Company's median sales growth is 20.3% of last 10 years
- Company's working capital requirements have reduced from 112 days to 84.6 days
Risks
- Stock is trading at 5.09 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -4.69%
- Company has a low return on equity of 4.90% over last 3 years.
- Dividend payout has been low at 13.6% of profits over last 3 years
- Company has high debtors of 161 days.
Compounded Sales Growth
- 10 Years
- +24%
- 5 Years
- +21%
- 3 Years
- +8%
- TTM
- +27%
Compounded Profit Growth
- 10 Years
- +19%
- 5 Years
- -2%
- 3 Years
- -17%
- TTM
- +23%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- +15%
- 3 Years
- +20%
- 1 Year
- +101%
Return on Equity
- 10 Years
- +9%
- 5 Years
- +7%
- 3 Years
- +5%
- Last Year
- +4%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 51.22% | 51.22% | 53.00% | 48.31% | -4.69 pp |
| FII | 4.57% | 4.46% | 4.11% | 4.13% | +0.02 pp |
| DII | 21.99% | 22.65% | 19.60% | 23.48% | +3.88 pp |
| Public | 22.21% | 21.67% | 23.27% | 24.07% | +0.80 pp |
Filed with NSE for Sept 2026: promoters 48.31%, public 51.69%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 16.51% (+0.74 pp)- Promoters48.3%
- Foreign institutions4.1%
- Mutual funds16.5%
- Insurance2.7%
- Other domestic institutions4.3%
- Retail14.9%
- Others9.2%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| SBI Contra Fund | 3.42% | 0.61% | +0.09 pp |
| Axis Small Cap Fund | 2.47% | 0.68% | +0.14 pp |
| Invesco India Smallcap Fund | 1.48% | 0.73% | +0.42 pp |
| ICICI Pru Multi Cap Fund | 0.89% | 0.40% | +0.40 pp |
| JM Flexi Cap Fund | 0.65% | 1.03% | +0.57 pp |
Scorecard
- Performance
- Avg
- Valuation
- High
- Growth
- Low
- Profitability
- Avg
- Entry point
- Avg
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 50.3%
- Downside volatility
- 47.3%
- Worst 5% of days
- 5.3%
- Average of that tail
- 6.7%
- Max drawdown (1Y)
- 38.5%
- Below its peak
- 2.7%
Against the market
- Beta vs Nifty 50
- 0.89
- Correlation
- 0.24
- Relative strength (3M)
- +18.6%
- ATR (14)
- 5.0%
Return
- Return 1M
- +11.9%
- Return 3M
- +22.5%
- Return 6M
- +64.4%
- Return 1Y
- +112.5%
- vs 200-day average
- +46.6%
Momentum
- RSI (14)
- 63.7
- MACD histogram
- 47.31
- Stochastic %K
- 88.9
- ADX (14)
- 25.4
- +DI / −DI
- 30.5 / 16.6
- Money flow index
- 84.0
Participation
- Delivery (20d avg)
- 43.8%
- vs its 60-day baseline
- +1.4 pts
- Volume vs 20-day
- +7.0σ
- Close vs day's VWAP
- +0.0%
- 52-week position
- 96 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
4 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — passed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — passed
- Current ratio improving — failed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — passed
- Asset turnover improving — failed
- Free cash flow
- -₹787 Cr
- FCF yield
- -9.4%
- Cash conversion
- -8.06
- Accruals ratio
- 0.090
- Net debt
- ₹1,196 Cr
- Net debt / equity
- 0.76
- EV / sales
- 9.43
- PEG
- 1.34
- Capex intensity
- 64.5%
- Revenue CAGR
- 28.6%
- Profit CAGR
- 126.6%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Insider trades
| Person | Type | Shares | Value | Disclosed |
|---|---|---|---|---|
SANJAY NATWARLAL MEHTA HUF Other · Market Sale | Sell | 61 | ₹1.5 L | 7 Nov 2026 |
SANJAY NATWARLAL MEHTA HUF Other · Market Sale | Sell | 2,300 | ₹57.1 L | 7 Nov 2026 |
SANJAY NATWARLAL MEHTA HUF Other · Market Sale | Sell | 61 | ₹1.5 L | 7 Nov 2026 |
SANJAY NATWARLAL MEHTA HUF Other · Market Sale | Sell | 2,300 | ₹57.1 L | 7 Nov 2026 |
HEENA HITESH RESHAMWALA Other · Gift | Sell | 354 | ₹0 | 29 Aug 2026 |
VIREN BHARATKUMAR RESHAMWALA . Other · Gift | Buy | 354 | ₹0 | 29 Aug 2026 |
CADAMBA SOLUTIONS PRIVATE LIMITED Promoter Group · Preferential Offer | Buy | 10,00,000 | ₹161 Cr | 20 Apr 2026 |
HARIN HARIDAS KANANI Promoters · Pledge Creation | Pledge | 20,19,167 | ₹0 | 13 Apr 2026 |
HARIN HARIDAS KANANI Promoters · Pledge Creation | Pledge | 13,19,083 | ₹0 | 30 Mar 2026 |
Haridas Kanani Family Trust Promoters · Gift | Buy | 52,76,500 | ₹0 | 2 Jan 2026 |
HARIDAS THAKARSHI KANANI Promoters · Gift | Sell | 57,78,500 | ₹0 | 2 Jan 2026 |
BEENA HARIDAS KANANI Promoter Group · Gift | Sell | 26,38,250 | ₹0 | 2 Jan 2026 |
Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.
Corporate actions
- dividendNot available — not reported in this filing
Dividend - Re 1 Per Share
13 Aug 2026ex-date - dividendNot available — not reported in this filing
Dividend - Re 1 Per Share
19 Sept 2025ex-date - dividend₹2.00
Annual General Meeting/Dividend - Rs 2 Per Share
19 Sept 2024ex-date - otherNot available — not reported in this filing
Extra Ordinary General Meeting
20 Oct 2023ex-date - dividend₹3.00
Annual General Meeting/Dividend - Rs 3 Per Share
25 Aug 2023ex-date - dividend₹2.75
Annual General Meeting/Dividend - Rs 2.75 Per Share
19 Sept 2022ex-date - otherNot available — not reported in this filing
Extra-Ordinary General Meting
23 Dec 2021ex-date - dividend₹2.25
Dividend - Rs 2.25 Per Share
16 Sept 2021ex-date - dividend₹2.00
Annual General Meeting/Dividend - Rs 2 Per Share
17 Sept 2020ex-date - dividend₹1.50
Dividend - Rs 1.50 Per Share
11 Sept 2019ex-date
Company announcements
Disclosure pertaining to approval by the Board of Neogen Morita New Materials Limited (NML) for issuance of equity shares of NML on Preferential Issue basis.
Intimation of credit rating.
Intimation of closure of trading window
Intimation of Analyst/Investor meet to be held on September 28, 2026.
Press Release titled " Neogen Chemicals raises approx INR 600 crore via its first ever QIP; Issue oversubscribed by 6.5x
Intimation of Analyst/Investor meeting to be held on September 22, 2026.
Outcome of Fund raising Committee meeting approving allotment of equity shares on QIP basis.
Outcome of fund raising committee approving allotment of equity shares on QIP basis.
Outcome of Fund raising committee approving allotment of equity shares on QIP basis
Outcome of Fund raising committee held today approving closure of issue, issue price, placement document, and confirmation of allocation note
Outcome of Fund Raising Committee held today approving closure of issue, issue price, placement document and confirmation of allocation note.
Approval of Issue opening date and Floor price and PPD.
Outcome of Fund raising committee meeting held today for opening of QIP issue.
Show Cause cum Demand Notice received from Office of the Commissioner CGST.
Approval for execution of Business Transfer Agreement between NIL and NML for sale/ transfer of undertaking/ assets as mentioned in detail in BTA by NIL to NML.
Filed with BSE (scrip 542665); the last 45 days. Documents open at bseindia.com.
SEBI filings & orders
From SEBI's website. An order may concern the company, its officers or trading in its shares, and may be under appeal - read the order itself. Personal identifiers are withheld.
Regulatory orders
- Order
Exemption order in the matter of Neogen Chemicals Ltd.
30 Dec 2025Read on SEBI
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlidesRecording
- May 2026TranscriptSlidesRecording
- Feb 2026TranscriptSlidesRecording
- Nov 2025TranscriptSlidesRecording
- Aug 2025Transcript
Credit ratings
- Rating update · 25 Sep from crisil
- Rating update · 17 Jul from crisil
- Rating update · 17 Jul 2025 from crisil
- Rating update · 14 Jun 2025 from crisil
- Rating update · 17 Mar 2025 from crisil
- Rating update · 27 Nov 2024 from crisil
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 1 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
NEOGEN CHEMICALS: common questions
Answered from the figures on this page.